SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: biowa who wrote (9)6/12/1997 4:47:00 PM
From: Pseudo Biologist   of 3044
 
biowa,

thanks for the thoughts and for advertising the revived thread elsewhere. I was wondering more about pre-clinical or clinical progress than about diagnostics. Your thoughts on a possible AFFX connection for diagnostics make sense. It's my impression that the BioTherapeutics unit may take a more aggressive development stand by going into the "easy" ways of exploiting knowledge of therapeutic targets - namely MAbs, perhaps antisense. ("easy" is meant to be in quotes; nothing is easy ...) But, of course, at the moment cannot even speculate about what projects they may pursue. Obesity does seem like one of their (MLNM's not necessarily BioTher) most mature areas.

Sorry to disapoint re. Pseudo; the name change was inspired by some fun exchange back in the Isis thread.

PB
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News